GLP-1 CARVE OUTS AND MENTAL HEALTH PARITY, HIPAA, AND EMPLOYEE DEMAND A handful of major carriers are reporting substantial losses in 2024, citing the cost of GLP-1 drugs (see, e.g., BCBS Massachusetts reports $400M loss driven by GLP-1 spending, Beckers Payer Issues, These losses will inevitably call even more attention to the GLP-1 spending by employer-sponsored group health plans
Because symptoms resemble allergies, the real cause is easily overlooked
The score was tied at 6-6 at halftime and USC led 9-8 at the end of the third quarter
What gets restored is the legal pathway for licensed 503A compounding pharmacies to prepare them under physician prescription
By alleviating inflammation, the BPC-157 peptide for tissue repair supports a more comfortable healing process, enabling individuals to resume their activities sooner
Raun et al